Evidence map›Paper›PMID 37619764›Full record

ReviewAdvances in nutrition (Bethesda, Md.)2023

The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update.

Qin Song, Xiaofeng Zhou, Kexin Xu, Sishi Liu, Xinqiang Zhu, Jun Yang

2 registry-linked trialsOpen access · hybridAbstract readReview
In one paragraph

Review in Advances in nutrition (Bethesda, Md.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 65 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 2 pooled it
16.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06889142 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Proof-of-Concept Study: Investigating the Impact of NMN Supplementation on CD4+ T Cell Recovery in Virologically Suppressed HIV Patients With Immunological Failure

TypeinterventionalSponsorTriHealth Inc.Ran2025 to 2025Enrolled7ConditionsHuman Immunodeficiency VirusArmsNicotinamide Mononucleotide
NCT06966583 phase1not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Safety and Preliminary Efficacy Study of NAD+Supplements (NMN) Combined With Radioimmunotherapy in Advanced Non Small Cell Lung Cancer Patients

TypeinterventionalSponsorSichuan UniversityRan2025 to 2027Enrolled20ConditionsSolid Tumor, Non Small Cell Lung CancerArmsNAD supplement, Radiotherapy, Immunotherapy
3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 2 syntheses or guidelines pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Aging and cancer: current understandings and future perspectives.Signal transduction and targeted therapy · 2026
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Skin Cancer Prevention and Antiaging: Role of Nicotinamide.International journal of molecular sciences · 2026
    Review
  14. Review
  15. Article
  16. Translational Geroscience Strategies for Delaying Multimorbidity.ACS pharmacology & translational science · 2026
    Review
  17. Review
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Qin SongDepartment of Occupational and Environmental Health, Hangzhou Normal University School of Public Health, Hangzhou, China.
Xiaofeng ZhouDepartment of Radiotherapy, The 2(nd) Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Kexin XuDepartment of Nutritional and Toxicological Science, Hangzhou Normal University School of Public Health, Hangzhou, China.
Sishi LiuDepartment of Nutritional and Toxicological Science, Hangzhou Normal University School of Public Health, Hangzhou, China.
Xinqiang ZhuCore Facility, The 4(th) Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, China. Electronic address: zhuxq@zju.edu.cn.
Jun YangDepartment of Nutritional and Toxicological Science, Hangzhou Normal University School of Public Health, Hangzhou, China; Zhejiang Provincial Center for Uterine Cancer Diagnosis and Therapy Research, The Affiliated Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China. Electronic address: junyanghzzju@163.com.
Hangzhou Normal University · CNSecond Affiliated Hospital of Zhejiang University · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The importance of nicotinamide adenine dinucleotide (NAD

Indexed as

NADNicotinamide MononucleotideAnimalsHumansModels, AnimalOxidative StressNADNicotinamide Mononucleotideantiagingclinical trialnicotinamide adenine dinucleotidenicotinamide mononucleotide

Identifiers

PMID37619764
PMCPMC10721522
OpenAlexW4386057078

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.